This inventor holds 1 USPTO granted patent. Top assignees: The University of Texas System, University System of Maryland. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,640 
1 out of 2,029 
Years Active: 2019
Title: Christopher Defilippi: Patent Work in Heart-Failure Risk Assessment.
Introduction
Christopher Defilippi is associated with Baltimore, Maryland, and has one patent listed in the information provided. His patent concerns assessing the risk of heart failure in older adults.
Latest Patents
Defilippi’s listed patent is “Methods for Assessing Differential Risk for Developing Heart Failure.” It describes predicting whether a patient aged 65 or older may face increased risk of developing heart failure. The method uses assay results measuring NT-proBNP, cardiac troponin T, or both in a patient specimen. Levels above those found in a control indicate increased risk.
Career Highlights
The organizations identified in connection with Defilippi’s career are the University System of Maryland and The University of Texas System. His listed patent reflects work on using cardiac biomarkers to support risk assessment.
Collaborations
The provided information names Stephen Seliger and Robert H. Christenson as Defilippi’s coworkers.
Conclusion
Christopher Defilippi’s patent focuses on biomarker-based assessment of heart-failure risk among older adults, connecting his listed work with academic institutions and named collaborators.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile